Carregant...
Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer
Although cisplatin is one of the most common antineoplastic drug, its successful utilisation in cancer treatment is limited by the drug resistance. Multiple attempts have been made to find potential cisplatin chemosensitisers which would overcome cancer cells resistance thus improving antineoplastic...
Guardat en:
| Publicat a: | Invest New Drugs |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer US
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7960624/ https://ncbi.nlm.nih.gov/pubmed/33159673 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-020-01032-y |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|